Return to Contents in this Issue

Original Article

 

Percutaneous Application of Peptidoglycan From Staphylococcus aureus Induces Infiltration of CCR4+ Cells Into Mouse Skin

 

K Matsui, A Nishikawa

Department of Immunobiology, Meiji Pharmaceutical University, Tokyo, Japan

J Investig Allergol Clin Immunol 2011; Vol. 21(5): 354-362

 

 Abstract


Background: The lesional skin of patients with atopic dermatitis has an increased number of type 2 helper T (TH2) cells in the dermis and is superficially colonized by Staphylococcus aureus. The purpose of this study was to determine the effects of peptidoglycan (PEG) from S aureus on TH2 cell induction in murine skin.

Methods: Mice were sensitized with house dust mite antigen (MA) by topical application to barrier-disrupted abdominal skin. Seven days after sensitization, PEG was applied to the barrier-disrupted dorsal skin. After a further 3 days, C-C chemokine receptor type 4–positive (CCR4+) cells were counted in the PEG-treated skin. The production of chemokine (C-C) motif ligand 17 (CCL17) (thymus- and activationregulated
chemokine) and CCL22 (macrophage-derived chemokine) in the skin was investigated using reverse transcriptase polymerase chain reaction and immunohistological analysis.

Results: Application of PEG to the dorsal skin of MA-sensitized mice led to a signifi cant increase in the number of cells expressing CCR4 in the dermis. The skin of PEG-treated mice showed an increased level of CCL17 mRNA expression, which coincided with TH2 cytokine mRNA expression. Immunohistological analysis demonstrated that levels of CCL17 transcripts corresponded to those of protein synthesis in the epidermis. CCL17 production was induced mainly by Langerhans cells stimulated with PEG. Furthermore, intraperitoneal injection of anti-CCL17 antibody abrogated the induction of CCR4+ cells in the skin.

Conclusion: These results suggest that PEG may induce TH2 cells in the skin through the production of CCL17 by Langerhans cells and would explain the role of colonization by S aureus in patients with atopic dermatitis.

Key words: Atopic dermatitis. Staphylococcus aureus. Peptidoglycan. CCL17. CCR4.